Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of Vonoprazan OD and Standard Tablets in Healthy Volunteers
NCT03808493Phase 1Completed
- Sponsor
- Takeda
- Start
- Jan 2019
- Primary completion
- Mar 2019
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of vonoprazan (4 arms), sponsored by Takeda. Primary endpoints: Area Under the Plasma Concentration-Time Curve From Time 0 to the Time of the Last Quantifiable Plasma Concentration for TAK-438 Free Base (TAK-438F), Maximum Observed Plasma Concentration for TAK-438F and 1 more. Started Jan 2019; status: completed.
02
Drugs
vonoprazan
Beyond the preview
Go deeper on NCT03808493.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03808493.